Is gene therapy soon going to be used clinically in advanced cancer of the prostate?
暂无分享,去创建一个
[1] J. Simons. Bioactivity of human GM-CSF gene therapy in metastatic renal cell carcinoma and prostate cancer. , 1997, Hinyokika kiyo. Acta urologica Japonica.
[2] R. Barth,et al. Tissue-specific expression of the human prostate-specific antigen gene in transgenic mice: implications for tolerance and immunotherapy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[3] J. Moul,et al. Inhibition of the growth of pre‐established subcutaneous tumor nodules of human prostate cancer cells by single injection of the recombinant adenovirus p53 expression vector , 1997, International journal of cancer.
[4] W. Fair,et al. Prostate-specific membrane antigen and other prostatic tumor markers on the horizon. , 1997, The Urologic clinics of North America.
[5] A. Belldegrun,et al. Identification of a positive regulatory element responsible for tissue-specific expression of prostate-specific antigen. , 1997, Cancer research.
[6] T. Thompson,et al. Adenovirus‐mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy leads to systemic activity against spontaneous and induced metastasis in an orthotopic mouse model of prostate cancer , 1997, International journal of cancer.
[7] D. Johnston,et al. Molecular therapy with recombinant p53 adenovirus in an androgen-independent, metastatic human prostate cancer model. , 1996, Human gene therapy.
[8] J. Eastham,et al. Prostate cancer gene therapy: herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models. , 1996, Human gene therapy.
[9] A. Passaniti,et al. Adenovirus-mediated wild-type p53 expression induces apoptosis and suppresses tumorigenesis of prostatic tumor cells. , 1995, Cancer research.
[10] E. Marshall. Gene therapy's growing pains , 1995, Science.
[11] E. Gelmann,et al. Androgens induce resistance to bcl-2-mediated apoptosis in LNCaP prostate cancer cells. , 1995, Cancer research.
[12] E. Gilboa,et al. Immunotherapy of prostate cancer in the Dunning rat model: use of cytokine gene modified tumor vaccines. , 1994, Cancer research.
[13] I. Pastan,et al. Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1. , 1992, Science.
[14] W. Isaacs,et al. Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles. , 1991, Cancer research.
[15] J. Gschwend. Apoptose – Grundlagen und Bedeutung des programmierten Zelltods für das Prostatakarzinom , 1996, Der Urologe A.